| |
| |
|
| Insider
Information: |
Auchincloss Thomas G |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
15,710 |
|
|
Indirect Shares
|
1,634 |
|
|
| Direct
Value |
$3,601 |
|
|
|
Indirect Value
|
$375 |
|
|
| Total
Shares |
17,344 |
|
|
| Total
Value |
$3,975 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 44.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Yield10 Bioscience Inc |
YTEN |
CFO and VP |
2007-06-28 |
15,710 |
2007-06-28 |
1,634 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2016-05-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,400) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,625) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
34,025 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2022-06-06 |
4 |
B |
$4.75 |
$28,500 |
D/D |
6,000 |
17,625 |
2.39 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,125 |
11,625 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2020-03-12 |
4 |
B |
$8.52 |
$12,773 |
D/D |
1,500 |
6,500 |
2.39 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2020-02-03 |
4 |
B |
$10.91 |
$10,910 |
D/D |
1,000 |
5,000 |
2.39 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-11-15 |
4 |
B |
$11.50 |
$11,500 |
D/D |
1,000 |
4,000 |
2.39 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2016-05-12 |
4 |
B |
$10.11 |
$20,211 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
CFO and VP |
• – – |
2007-06-28 |
4 |
AS |
$24.02 |
$981,483 |
D/D |
(40,865) |
15,710 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
CFO and VP |
• – – |
2007-06-28 |
4 |
OE |
$3.30 |
$134,855 |
D/D |
40,865 |
56,575 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
CFO and VP |
• – – |
2006-12-13 |
4 |
OE |
$13.21 |
$13,487 |
D/D |
1,021 |
15,710 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
CFO and VP |
• – – |
2006-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,078 |
14,689 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
CFO and VP |
• – – |
2006-11-10 |
4 |
B |
$14.00 |
$14,000 |
D/D |
1,000 |
1,611 |
2.74 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
CFO and VPOfficer |
• – – |
2006-11-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,634 |
|
- |
|
| YTEN |
Yield10 Bioscience Inc |
CFO and VPOfficer |
• – – |
2006-11-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
611 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
